Clearlake and Charlesbank to inject $175m into distressed Symplr
Tuesday, September 22, 2026 · first reported by Private Equity Wire
Clearlake Capital and Charlesbank Capital are providing $175M preferred equity to healthcare software company Symplr as part of a restructuring to extend debt maturities; second-lien lenders adding $103.5M first-out second-lien facility.
- Also named
- Charlesbank Capital Partners, Symplr
- Deal value
- $175M
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore in Deals
From the same day- Platinum Equity completes $6.6bn sale of Urbaser to Blackstone and EQTPE Hub
- Hg agrees majority investment in Greek software firm EnterSoftone in €1bn dealPE Hub +1
- Bain Capital agrees $230m purchase of SOLitude Lake Management from RentokilPE Hub +1
- Softcat Crosses the Atlantic with H.I.G.’s GDTPrivate Equity Professional
- H.I.G. Capital to Take MISTRAS Group Private at $866 MillionPrivate Equity Professional
- Cornell Capital acquires insurance claims services provider Hancock Claims ConsultantsPE Hub